Dr. Agarwal’s Health Care Limited offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.

As of September 30, 2024, there were 737 doctors providing care to patients across the company’s facilities. During this period, the company served 2.13 million patients and performed 220,523 surgeries. In the six months leading up to September 30, 2024, they served 1.15 million patients and conducted 140,787 surgeries. (Source: As per RHP)

For the year/period ended (Rs. in Cr.)

For year/ period ended ( in Cr.)

• Largest eye care services provider in India with a trusted brand
• End-to-end, comprehensive eye care services offering
• Scalable, asset-light, hub-and-spoke operating model
• Proven clinical excellence is driven by a strong clinical board and a history of surgical innovations.
• Doctor-promoters leading a team of qualified medical professionals and supported by experienced management
• Proven track record of delivering organic growth, integrating and scaling acquisitions and improving operating profitability

1. Repayment/prepayment, in part or full, of certain of the borrowings and
2. General corporate purposes and unidentified inorganic acquisition.

The company is engaged in eye care business providing all eye health related treatments. The Company has nearly 25% market share in its business of eye-care related services. Based on recent financial performance, the issue appears aggressively priced. Hence, investor may subscribe for long term considering future prospects.